The rise and fall and rise again of 23andMe.
Check Hayden, Erika
The rise and fall and rise again of 23andMe. [electronic resource] - Nature 10 2017 - 174-177 p. digital
Publication Type: Journal Article
1476-4687
10.1038/550174a doi
Antibodies, Monoclonal--adverse effects
Benzylisoquinolines--therapeutic use
Biosensing Techniques
Bloom Syndrome--diagnosis
Cardiovascular Diseases--drug therapy
Disclosure--ethics
Drug Discovery--methods
False Positive Reactions
Gaucher Disease--drug therapy
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Genetic Testing--economics
Genome-Wide Association Study
Heredity
Humans
Iceland
Immune System Diseases--drug therapy
Information Dissemination
Neoplasms--diagnosis
Parkinson Disease--drug therapy
Pharmacogenetics
Predictive Value of Tests
Reproducibility of Results
Self Report
Skin Diseases--drug therapy
Translational Research, Biomedical
United States
United States Food and Drug Administration--legislation & jurisprudence
The rise and fall and rise again of 23andMe. [electronic resource] - Nature 10 2017 - 174-177 p. digital
Publication Type: Journal Article
1476-4687
10.1038/550174a doi
Antibodies, Monoclonal--adverse effects
Benzylisoquinolines--therapeutic use
Biosensing Techniques
Bloom Syndrome--diagnosis
Cardiovascular Diseases--drug therapy
Disclosure--ethics
Drug Discovery--methods
False Positive Reactions
Gaucher Disease--drug therapy
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Genetic Testing--economics
Genome-Wide Association Study
Heredity
Humans
Iceland
Immune System Diseases--drug therapy
Information Dissemination
Neoplasms--diagnosis
Parkinson Disease--drug therapy
Pharmacogenetics
Predictive Value of Tests
Reproducibility of Results
Self Report
Skin Diseases--drug therapy
Translational Research, Biomedical
United States
United States Food and Drug Administration--legislation & jurisprudence